Report #2850699

Received Jul 22, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (2)

Injection site painInjection site warmth

Symptom narrative

sharp pain near injection site; Hot at injection site; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site pain (Verbatim: sharp pain near injection site) and injection site warmth (Verbatim: Hot at injection site). The outcome of the injection site pain and injection site warmth were not reported. It was unknown if the reporter considered the injection site pain and injection site warmth to be related to Shingrix. It was unknown if the company considered the injection site pain and injection site warmth to be related to Shingrix. Additional Information: GSK Receipt date: 12-JUL-2025 The patient had hot and sharp pain near injection site.